Tentech Inc. Enters into Exclusive Distribution Agreement for 10THERMA in the U.S. with BENEV

Tentech Inc., a medical device manufacturer, announced that it has signed an exclusive contract with BENEV Company Inc., one of the leading companies in the U.S.

According to Tentech Inc., “This contract is valued at approximately 7.26 million U.S. dollars (about 10 billion KRW, with 1378 KRW =1 dollar), and it is expected to grow as tip sales become more active.”

BENEV Company Inc., established in California in 2000 and now a partner with Tentech Inc,, is an FDA-registered pharmaceutical manufacturer specializing in medical devices and clinical products. BENEV’s products are distributed globally through a hospital network.

10THERMA, with a maximum output of 400W, is a 6.78MHz monopolar radiofrequency (MRF) treatment device. 10THERMA can deliver RF energy to the dermis, generating heat through the skin’s electrical resistance.

The 5㎠ face tip of 10THERMA is wider than those of other RF devices, allowing for 25% more energy coverage per shot. 10THERMA features an S.T.C. (Smart Temperature Cooling) system, which emits a total of seven cooling pulses during a single shot.

’10THERMA’ is equipped with impedance matching technology that helps adjust precise targeted energy for individuals. Additionally, this treatment is non-invasive, resulting in no downtime and less pain.

Mr. Han, CEO of Tentech Inc., mentioned, “I hope this exclusive contract will be a trigger to gain not only the American market but also the global market,” and added, “As a global medical company, we aim to establish a strong presence in the U.S.”

Meanwhile, Tentech Inc. received 510(k) clearance for 10THERMA from the U.S. FDA (Food and Drug Administration) last year and has attended many conferences and exhibitions for American dermatologists, such as ‘AAD 2024’ (American Academy of Dermatology) and ‘ASLMS 2024’ (American Society for Laser Medicine and Surgery).

Exit mobile version